Session » Osteoporosis and Metabolic Bone Disease: Clinical Aspects and Pathogenesis
-
Abstract Number: 862
Ten-Year Incidence of Self-Reported Nonvertebral Fractures in 9,720 Japanese Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study
-
Abstract Number: 863
Romosozumab Administration Is Associated With Significant Improvements In Lumbar Spine and Hip Volumetric Bone Mineral Density and Content Compared With Teriparatide
-
Abstract Number: 864
Further Reduction In Nonvertebral Fracture Rate Is Observed Following 3 Years Of Denosumab Treatment: Results With Up To 7 Years In The Freedom Extension
-
Abstract Number: 865
Vertebral Fractures In The 3 Year Period Following Steroid Initiation Among Children With Chronic Illnesses
-
Abstract Number: 866
Use Of Non Steroidal Anti-Inflammatory Drugs Prevent Bone Loss In Patients With Early Inflammatory Back Pain: Results From The DESIR Cohort
-
Abstract Number: 867
Reduced Hip Cortical Porosity Upon Denosumab Treatment: A Likely Mechanism Contributing To The Reduction Of Hip Fracture Risk In Women With Osteoporosis
-
Abstract Number: 1215
Human Immunodeficiency Virus Infection and Fracture Risk-a Meta-analysis
-
Abstract Number: 1217
Determination Of Vitamin D Level Prior To The Initiation Of Bisphosphonate Therapy
-
Abstract Number: 1218
Incidence Of and Risk Factors For Clinical Fractures In Patients With Systemic Lupus Erythematosus and Matched Controls: A Population-Based Study In The United Kingdom
-
Abstract Number: 1219
Phase 3 Fracture Trial Of Odanacatib For Osteoporosis – Baseline Characteristics and Study Design
-
Abstract Number: 1220
Rheumatoid Arthritis Characteristics and Fracture Risk: A Population-Based Study
-
Abstract Number: 1221
The Effects Of Hyperthyroidism On Bone Mineral Density At Different Sites- An Observational Case-Control Study
-
Abstract Number: 1222
Analysis Of Corelation Of Bone Mineral Density Of Spine With Other Sites In Ankylosing Spondylitis As Compared To Rheumatoid Arthritis and Control Populations
-
Abstract Number: 1223
Monitoring Osteoporosis Therapy: Can FRAX Help To Assess Success Or Failure In Achieving Treatment Goals?
-
Abstract Number: 1224
Prednisone Has No Effect On Odanacatib Pharmacokinetics In Healthy Subjects
-
Abstract Number: 1226
Adherence With Current Osteoporosis Treatment Guidelines Among Rheumatologists Caring For Patients With Rheumatoid Arthritis Using Items From The Fracture Risk Assessment Tool Score
-
Abstract Number: 1228
Trabecular BONE Score In Rheumatoid Arthritis and Ankylosing Spondylitis and Changes During LONG TERM Treatment With TNFA Blocking Agents
-
Abstract Number: 1229
A Before and After Comparison Of The Effects Of Monitoring On a Quality Indicator For glucocorticoid–induced Osteoporosis In a Japanese Hospital
-
Abstract Number: 1230
Analysis Of Fracture Risk Assessment Score (FRAX) Correlation With Bone Mineral Density (BMD) In Males and Post-Menopausal Females
-
Abstract Number: 1231
The Quality Of Life and Resource Use Related To Hip Fractures Based On Data From The International Costs and Utilities Related To Osteoporotic Fractures Study
-
Abstract Number: 1232
Osteoporosis In Rheumatoid Arthritis – Still a Threat In The Biologic Era?
-
Abstract Number: 1233
Strontium Ranelate Uncouples Bone Resorption From Bone Formation In Osteoporotic Patients With Or Without Clinical Risk Factors
-
Abstract Number: 1234
Effects Of Biological Therapy In Bone Metabolism In Patients With Chronic Inflammatory Arthropathies
-
Abstract Number: 1235
Predictors Of Fracture In Patients With Osteopenia: Data From An Observational Cohort
-
Abstract Number: 1236
Outcomes and Costs Of Sacral Insufficiency Fractures
-
Abstract Number: 1238
Persistence At 12 Months With Denosumab (Prolia®) In Postmenopausal Women With Osteoporosis: Interim Results From a Prospective Observational Study
-
Abstract Number: 1239
The Effects Of Hyperparathyroidism On Body Mass Index and Bone Mineral Density- An Observational Case-Control Study
-
Abstract Number: 1240
Study On The Relationship Between The Preoperative Stay and Morbimortality In Patients With Hip Fracture
-
Abstract Number: 1241
A Low Serum 25(OH) Vitamin D Level As a Risk Factor For Incidence and Severity Of Vertebral Fracture In Glucocorticoid-Induced Osteoporosis In Japan
-
Abstract Number: 1242
A Prospective Randomized Open Label Trial To Evaluate The Effect Of Food On Vitamin D Absorption
-
Abstract Number: 1243
Osteoporosis Medication Adherence: Reasons For Stopping and Not Starting
-
Abstract Number: 1244
Low Bone Mineral Density In African-American Males May Be More Prevalent Than Previously Reported and Exhibits Association With Low BMI But Not Older Age – Results Of a Retrospective Cohort Analysis
-
Abstract Number: 1245
The Differential Effect Of Smoking On Bone Mineral Density At The Lumbar Spine and Neck Of Femur In Each Gender: An Observational Study
-
Abstract Number: 1246
Efficacy Of a 6-Month Treatment With Strontium Ranelate 2g/Day In The Improvement Of Long Bone Fractures With Delayed-Union Or Non-Union
-
Abstract Number: 1247
Association Between Bisphosphonate Switching Behavior and Cost Outcomes In Postmenopausal United States Veterans
-
Abstract Number: 1248
Prevalence Of Vitamin D Inadequacy In European Postmenopausal Women Aged Over 80 Years